Cargando…

Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC)

PURPOSE: Management of progressive, metastatic radioactive iodine refractory differentiated thyroid cancer (RAIR-DTC) has been a great challenge due to its poor prognosis and limited treatment options. Recently, apatinib, an orally anti-angiogenic tyrosine kinase inhibitor (TKI) is reported to be us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liang, You, Qinqin, Wang, Jun, Wang, Hanjin, Li, Shaohua, Tian, Rui, Yao, Xiaocheng, Wu, Wenyu, Zhang, Lele, Wang, Feng, Lin, Yansong, Li, Shuren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474580/ https://www.ncbi.nlm.nih.gov/pubmed/35767182 http://dx.doi.org/10.1007/s12020-022-03113-9

Ejemplares similares

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma
por: Chi, Yanyan, et al.
Publicado: (2022)

The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo
por: Yu, Fangqin, et al.
Publicado: (2021)

Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer
por: Lin, Yansong, et al.
Publicado: (2017)

Development and validation of the information needs questionnaire for differentiated thyroid cancer patient with radioactive iodine therapy (INQ‐DTC)
por: Zhang, Jing, et al.
Publicado: (2021)

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial
por: Lin, Yansong, et al.
Publicado: (2021)

Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019)

DTC-and-Me: Patient, Provider, Proteins and Regulators
por: Steele, Fintan R., et al.
Publicado: (2014)

Rutherford-Appleton : Le charme discret des DTC
Publicado: (1986)

Beyond clinical utility: The multiple values of DTC genetics
por: Turrini, Mauro, et al.
Publicado: (2016)

Comparison of ANN- and GA-based DTC eCAR
por: Banda, Gururaj, et al.
Publicado: (2021)

Sensorless based SVPWM-DTC of AFPMSM for electric vehicles
por: Saleh, Saber M., et al.
Publicado: (2022)

Efficacy evaluation and influencing factor analysis of postoperative (131)I for the treatment of primary hyperthyroidism combined with differentiated thyroid cancer (DTC)—a retrospective cohort study
por: Zhao, Zilong, et al.
Publicado: (2023)

Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17
por: Chen, Ran, et al.
Publicado: (2019)

Constructing Identities: The Implications of DTC Ancestry Testing for Tribal Communities
por: Walajahi, Hina, et al.
Publicado: (2019)

Drug and Therapeutics Committee (DTC) evolvement and expanded scope in Ethiopia
por: Seyoum, Habtamu, et al.
Publicado: (2023)

Molecular evidence for sulfurization of molybdenum dithiocarbamates (MoDTC) by zinc dithiophosphates: a key process in their synergetic interactions and the enhanced preservation of MoDTC in formulated lubricants?
por: Kiw, Yu Min, et al.
Publicado: (2022)

Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
por: Wang, Jiaqiang, et al.
Publicado: (2023)

Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report
por: Liang, Li-Jun, et al.
Publicado: (2018)

Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
por: Gu, Huiying, et al.
Publicado: (2020)

Application of apatinib after multifaceted therapies for metastatic breast cancer
por: Wang, Jue, et al.
Publicado: (2020)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

Activity and safety of apatinib monotherapy or apatinib combined with chemotherapy for patients with metastatic or unresectable osteosarcoma over the age of 40 years: A retrospective analysis
por: Gong, Taojun, et al.
Publicado: (2022)

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision
por: Czarniecka, Agnieszka, et al.
Publicado: (2010)

XRCC1 Gene Polymorphisms and the Risk of Differentiated Thyroid Carcinoma (DTC): A Meta-Analysis of Case-Control Studies
por: Bao, Yi, et al.
Publicado: (2013)

Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
por: Cai, Zhaolun, et al.
Publicado: (2019)

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
por: Hu, Xichun, et al.
Publicado: (2014)

The Influences of TSH Stimulation Level, Stimulated Tg Level and Tg/TSH Ratio on the Therapeutic Effect of (131)I Treatment in DTC Patients
por: Zheng, Wei, et al.
Publicado: (2021)

Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
por: Du, Wei, et al.
Publicado: (2022)

Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
por: Li, Cheng-Ming, et al.
Publicado: (2017)

Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report
por: Wang, Xiaolu, et al.
Publicado: (2021)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Chain DTC Diabetes: new payment system to stimulate integrated care in the Netherlands
por: de Bruijn, Els M.
Publicado: (2009)

Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients
por: Schoonen, Lise, et al.
Publicado: (2021)

Short- and intermediate-term impact of DTC telemedicine consultations on subsequent healthcare consumption
por: Dahlgren, Cecilia, et al.
Publicado: (2023)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
por: Hou, Xi-Xi, et al.
Publicado: (2023)

The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma: A case report
por: Han, Zonghong, et al.
Publicado: (2018)

Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAF(V600E) Mutations
por: Su, Yanjun, et al.
Publicado: (2021)

Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
por: Rong, Xuetong, et al.
Publicado: (2022)

Response to apatinib and camrelizumab combined treatment in a radioiodine refractory differentiated thyroid cancer patient resistant to prior anti-angiogenic therapy: A case report and literature review
por: Li, Jiayi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0iuhanhigf823of3daj57mhr3a